Karaca, Ender
Posey, Jennifer E.
Coban Akdemir, Zeynep
Pehlivan, Davut
Harel, Tamar
Jhangiani, Shalini N.
Bayram, Yavuz
Song, Xiaofei
Bahrambeigi, Vahid
Yuregir, Ozge Ozalp
Bozdogan, Sevcan
Yesil, Gozde
Isikay, Sedat
Muzny, Donna
Gibbs, Richard A.
Lupski, James R.
Article History
Received: 20 August 2017
Accepted: 24 January 2018
First Online: 26 April 2018
Disclosure
: Baylor College of Medicine and Miraca Holdings have formed a joint venture with shared ownership and governance of Baylor Genetics, formerly the Baylor Miraca Genetics Laboratories, which performs clinical exome sequencing. J.R.L. serves on the Scientific Advisory Board of Baylor Genetics. J.R.L. has stock ownership in 23andMe, is a paid consultant for Regeneron Pharmaceuticals, has stock options in Lasergen, and is a coinventor on multiple US and European patents related to molecular diagnostics for inherited neuropathies, eye diseases, and bacterial genomic fingerprinting. The other authors declare no conflict of interest.